lansoprazole has been researched along with Dystonia in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Dystonia: An attitude or posture due to the co-contraction of agonists and antagonist muscles in one region of the body. It most often affects the large axial muscles of the trunk and limb girdles. Conditions which feature persistent or recurrent episodes of dystonia as a primary manifestation of disease are referred to as DYSTONIC DISORDERS. (Adams et al., Principles of Neurology, 6th ed, p77)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Sharif, A | 1 |
Carr, L | 1 |
Saliakellis, E | 1 |
Chakraborty, H | 1 |
1 other study available for lansoprazole and Dystonia
Article | Year |
---|---|
Paroxysmal head drops with ataxia-like symptoms presenting as Sandifer syndrome in a 3-year old girl.
Topics: Ataxia; Child, Preschool; Diagnosis, Differential; Dystonia; Female; Gastroesophageal Reflux; Humans | 2020 |